Login
$MNOV
$1.33 -$0.01 (0.6%) After hours

$MNOV 8-K SEC Filings

Filed On Filing
16 Nov 2026 8-K: Departure/Election of Directors or Officers; Compensation
28 Sep 2026 8-K: Entry into a Material Definitive Agreement

On September 23, 2026, MediciNova, Inc. (the “Company”) amended its Lease (the “Lease”), dated July 20, 2021, between the Company and the Irvine Company LLC pursuant to a First Amendment to the Lease, dated as of September 23, 2026 (the ...

02 Sep 2026 8-K: Termination of a Material Definitive Agreement

On August 31, 2026, MediciNova, Inc. (the “Company”) delivered to YA II PN, LTD. (“Yorkville”), a Notice of Termination, informing Yorkville of the Company’s election to terminate the Standby Equity Purchase Agreement, dated as of July 3...

19 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

24 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

MediciNova, Inc. (the “Company”) held its 2026 annual meeting of stockholders on June 23, 2026 (the “Annual Meeting”). The Company filed its definitive proxy statement for the proposals voted upon at the Annual Meeting with the Securitie...

20 Feb 2026 8-K: Results of Operations and Financial Condition

Kazuko Matsuda, Director and CMO, Vice President, Representative of the Tokyo Office

30 Dec 2025 8-K: Entry into a Material Definitive Agreement

MediciNova, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with Lucid Capital Markets, LLC (the “Agent”), as follows:

01 Aug 2025 8-K: Entry into a Material Definitive Agreement

THIS STANDBY EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of July 30, 2025 is made by and between YA II PN, LTD., a Cayman Islands exempt limited company (the “Investor”), and MEDICINOVA, INC, a company incorporated under the la...

18 Jun 2025 8-K: Submission of Matters to a Vote of Security Holders

MediciNova, Inc. (the “Company”) held its 2025 annual meeting of stockholders on June 17, 2025 (the “Annual Meeting”). The Company filed its definitive proxy statement for the proposals voted upon at the Annual Meeting with the Securitie...

11 Mar 2025 8-K: Regulation FD Disclosure

Forward-Looking Statements Statements in this presentation that are not historical in nature constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. ...

12 Jun 2024 8-K: Submission of Matters to a Vote of Security Holders

MediciNova, Inc. (the “Company”) held its 2024 annual meeting of stockholders on June 11, 2024 (the “Annual Meeting”). The Company filed its definitive proxy statement for the proposals voted upon at the Annual Meeting with the Securitie...

01 Apr 2024 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

07 Aug 2023 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

22 Jun 2023 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

14 Jun 2023 8-K: Submission of Matters to a Vote of Security Holders

MediciNova, Inc. (the “Company”) held its 2023 annual meeting of stockholders on June 13, 2023 (the “Annual Meeting”). The Company filed its definitive proxy statement for the proposals voted upon at the Annual Meeting with the Securitie...

26 Apr 2023 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

21 Jun 2022 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

15 Jun 2022 8-K: Submission of Matters to a Vote of Security Holders

MediciNova, Inc. (the “Company”) held its 2022 annual meeting of stockholders on June 14, 2022 (the “Annual Meeting”). The Company filed its definitive proxy statement for the proposals voted upon at the Annual Meeting with the Securitie...

05 Apr 2022 8-K: Other Events

On March 30, 2022, MediciNova, Inc. was notified that Genzyme Corporation, a subsidiary of Sanofi, filed its First Amended Complaint, which included a claim for infringement of U.S. Patent No. 9,051,542, on February 23, 2022 in a lawsuit...

02 Aug 2021 8-K: Departure/Election of Directors or Officers; Compensation

This Agreement is entered into August 1, 2021 between Signature Analytics LLC (“SA”) and MediciNova, Inc. (“Client”) located at 4275 Executive Square, Suite 300, La Jolla, CA 92037.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support